We aim to study the association of hyperlipidemia and statin use with COVID-19 severity. We
analysed a retrospective cohort of 717 patients admitted to a tertiary centre in Singapore for …

Background There is an urgent need for novel therapeutic strategies for reversing COVID-19-
related lung inflammation. Recent evidence has demonstrated that the cholesterol-lowering …

Objective To investigate the association between recent statin exposure and risk of severe
COVID-19 infection and all-cause mortality in patients with COVID-19 in Denmark. Design …

The coronavirus disease-2019 (COVID-19) is caused by SARS-CoV-2, leading to acute
respiratory distress syndrome (ARDS), thrombotic complications, and myocardial injury …

Background The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has profoundly affected the …

Background Epidemiological evidence suggests that anti-inflammatory and
immunomodulatory properties of statins may reduce the risk of infections and infection …

Background Coronavirus disease 2019 (COVID-19) might affect everyone, but people with
comorbidities such as hypertension and cardiovascular disease (CVD) may often have more …

Purpose Observations studies have shown that prior use of statins is associated with a
reduced risk of adverse clinical outcomes in patients with COVID-19. However, the available …

Introduction Statins may reduce a cytokine storm, which has been hypothesized as a
possible mechanism of severe COVID-19 pneumonia. The aim of this study was to conduct a …

Background Statins are widely used to treat people with metabolic and cardiovascular
disorders. The effect of statins on coronavirus disease 2019 (COVID-19) is unclear. To …